niacinamide has been researched along with Acute Disease in 47 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Acute Disease: Disease having a short and relatively severe course.
Excerpt | Relevance | Reference |
---|---|---|
"This study was designed to assess the cardioprotective effect of intravenous nicorandil, a potassium channel opener, in preventing reperfusion injury in acute myocardial infarction." | 9.08 | Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction. ( Daikoku, S; Goto, Y; Haze, K; Itoh, A; Kobayashi, Y; Miyazaki, S; Nonogi, H; Ohshima, S, 1998) |
" In this study, the potential of interleukin-8 (IL-8) labeled with (99m)Tc using hydrazinonicotinamide (HYNIC) to image IBD was investigated in a rabbit model of acute colitis and compared with that of (99m)Tc-HMPAO-labeled granulocytes." | 7.71 | Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits. ( Boerman, OC; Corstens, FH; Gratz, S; Oyen, WJ; Rennen, HJ, 2001) |
"Comparative hemodynamic effects of nicorandil (NCR), nitroglycerin (NTG) and cromakalim (CRM) were examined in a canine model of acute congestive heart failure (CHF)." | 7.70 | Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim. ( Koyama, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M, 1998) |
"Suddenly, he developed left cardiac failure, and he died 6 days later through a rapid clinical course that included circulatory failure, abnormal glucose tolerance, disseminated intravascular coagulation, and multiple organ failure." | 5.38 | [A case of fatal clinical course with reversible acute cardiac failure and glucose intolerance during sorafenib therapy for metastatic renal cell carcinoma]. ( Kimura, T; Miyagawa, T; Suetomi, T; Tsutsumi, M, 2012) |
"Sorafenib was eventually discontinued, and the pancreatitis resolved." | 5.34 | Acute pancreatitis associated with sorafenib. ( Li, M; Srinivas, S, 2007) |
"This study was designed to assess the cardioprotective effect of intravenous nicorandil, a potassium channel opener, in preventing reperfusion injury in acute myocardial infarction." | 5.08 | Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction. ( Daikoku, S; Goto, Y; Haze, K; Itoh, A; Kobayashi, Y; Miyazaki, S; Nonogi, H; Ohshima, S, 1998) |
"Increased of proinflammatory cytokines levels, including interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) on severe acute pancreatitis causes vasodilatation, increased permeability of the wall, accumulation of fluid in lung tissue and pleural sinuses." | 3.81 | [PREVENTION AND CORRECTION OF PULMONARY COMPLICATIONS FOR SEVERE ACUTE PANCREATITIS]. ( Fedorkiv, MB, 2015) |
" In this study, the potential of interleukin-8 (IL-8) labeled with (99m)Tc using hydrazinonicotinamide (HYNIC) to image IBD was investigated in a rabbit model of acute colitis and compared with that of (99m)Tc-HMPAO-labeled granulocytes." | 3.71 | Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits. ( Boerman, OC; Corstens, FH; Gratz, S; Oyen, WJ; Rennen, HJ, 2001) |
"Comparative hemodynamic effects of nicorandil (NCR), nitroglycerin (NTG) and cromakalim (CRM) were examined in a canine model of acute congestive heart failure (CHF)." | 3.70 | Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim. ( Koyama, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M, 1998) |
"The hexose monophosphate shunt inhibitor 6-aminonicotinamide was observed to have an anti-inflammatory effect in the treatment of experimental uveitis." | 3.68 | Pharmacologic modulation of acute uveitis with aminonicotinamide. ( Donoso, LA; Gregerson, D; Marak, GE; Rao, NA; Sery, TW, 1990) |
"Sorafenib is a small molecule inhibitor of RAF kinase, VEGFR-2, c-KIT, and FLT3." | 2.75 | A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study. ( Brandwein, J; Buckstein, R; Crump, M; Eisenhauer, E; Hedley, D; Kamel-Reid, S; Kassis, J; Leber, B; Matthews, J; McIntosh, L; Minden, M; Robinson, S; Seymour, L; Turner, R; Wells, R, 2010) |
"Suddenly, he developed left cardiac failure, and he died 6 days later through a rapid clinical course that included circulatory failure, abnormal glucose tolerance, disseminated intravascular coagulation, and multiple organ failure." | 1.38 | [A case of fatal clinical course with reversible acute cardiac failure and glucose intolerance during sorafenib therapy for metastatic renal cell carcinoma]. ( Kimura, T; Miyagawa, T; Suetomi, T; Tsutsumi, M, 2012) |
"Duration of comatose state and artificial lung ventilation was reduced from 64." | 1.36 | [The use of cytoflavin in combined neurometabolic therapy of acute cerebral insufficiency associated with acute poisoning with neurotropic poisons]. ( Aleksandrov, MV; Andrianov, AIu; Batotsyrenov, BV; Kuznetsov, OA; Loladze, AT; Shikalova, IA; Vasil'ev, SA, 2010) |
"Sorafenib response was associated with an inhibition of the antiapoptotic FLT3-ITD target Stat-5 in vivo." | 1.35 | Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation. ( Burchert, A; Chaturvedi, A; Eilers, M; Enghofer, E; Metzelder, S; Neubauer, A; Teichler, S; Wang, Y; Wanzel, M; Wollmer, E, 2009) |
"Sorafenib was eventually discontinued, and the pancreatitis resolved." | 1.34 | Acute pancreatitis associated with sorafenib. ( Li, M; Srinivas, S, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (14.89) | 18.7374 |
1990's | 7 (14.89) | 18.2507 |
2000's | 10 (21.28) | 29.6817 |
2010's | 22 (46.81) | 24.3611 |
2020's | 1 (2.13) | 2.80 |
Authors | Studies |
---|---|
Kalantari, S | 1 |
Chashmniam, S | 1 |
Nafar, M | 1 |
Samavat, S | 1 |
Rezaie, D | 1 |
Dalili, N | 1 |
Qiu, QC | 1 |
Wang, C | 1 |
Bao, XB | 1 |
Yang, J | 1 |
Shen, HJ | 1 |
Ding, ZX | 1 |
Liu, H | 1 |
He, J | 1 |
Yao, H | 1 |
Chen, SN | 1 |
Li, Z | 1 |
Xue, SL | 1 |
Liu, SB | 1 |
Volchegorskiĭ, IA | 1 |
Rassokhina, LM | 1 |
Ermakova, SG | 1 |
Miroshnichenko, IIu | 1 |
Zinov'ev, EV | 1 |
Nesterov, IuV | 1 |
Lagvilava, TO | 1 |
Mikhaĭlova, EV | 1 |
Danilova, AN | 1 |
Chudakova, TK | 1 |
Romanovskaia, AV | 1 |
Dubovitskaia, NA | 1 |
Belova, AE | 1 |
Livanov, GA | 2 |
Lodiagin, AN | 2 |
Andrianov, AIu | 2 |
Batotsyrenov, BV | 6 |
Nikolaeva, IP | 1 |
Fedorkiv, MB | 1 |
Airiau, K | 1 |
Prouzet-Mauléon, V | 1 |
Rousseau, B | 1 |
Pigneux, A | 1 |
Jeanneteau, M | 1 |
Giraudon, M | 1 |
Allou, K | 1 |
Dubus, P | 1 |
Belloc, F | 1 |
Mahon, FX | 1 |
Bagnenko, SF | 1 |
Sinenchenko, GI | 1 |
Kurygin, AA | 1 |
Chupris, VG | 1 |
Llanos, L | 1 |
Bellot, P | 1 |
Zapater, P | 1 |
Pérez-Mateo, M | 1 |
Such, J | 1 |
Metzelder, S | 1 |
Wang, Y | 1 |
Wollmer, E | 1 |
Wanzel, M | 1 |
Teichler, S | 1 |
Chaturvedi, A | 1 |
Eilers, M | 1 |
Enghofer, E | 1 |
Neubauer, A | 1 |
Burchert, A | 1 |
Tadmor, T | 1 |
Tallman, MS | 1 |
Polliack, A | 1 |
Crump, M | 1 |
Hedley, D | 1 |
Kamel-Reid, S | 1 |
Leber, B | 1 |
Wells, R | 1 |
Brandwein, J | 1 |
Buckstein, R | 1 |
Kassis, J | 1 |
Minden, M | 1 |
Matthews, J | 1 |
Robinson, S | 1 |
Turner, R | 1 |
McIntosh, L | 1 |
Eisenhauer, E | 1 |
Seymour, L | 1 |
Saadati, H | 1 |
Saif, MW | 1 |
Amagyrov, VP | 1 |
Batotsyrenova, KhV | 1 |
Herden, U | 1 |
Fischer, L | 1 |
Schäfer, H | 1 |
Nashan, B | 1 |
von Baehr, V | 1 |
Sterneck, M | 1 |
Liu, J | 1 |
Wu, JQ | 1 |
Yang, JJ | 1 |
Wei, JY | 1 |
Gao, WN | 1 |
Guo, CJ | 1 |
Aleksandrov, MV | 1 |
Vasil'ev, SA | 3 |
Kuznetsov, OA | 2 |
Shikalova, IA | 2 |
Loladze, AT | 4 |
Pardee, TS | 1 |
Zuber, J | 1 |
Lowe, SW | 1 |
Shestakov, VV | 1 |
Kosenkova, NV | 1 |
Kichigina, EV | 1 |
Larikova, TN | 1 |
Starikova, NL | 1 |
Kliuĭko, DA | 1 |
Korik, VE | 1 |
Zhidkov, SA | 1 |
Shilov, VV | 3 |
Kimura, T | 1 |
Suetomi, T | 1 |
Miyagawa, T | 1 |
Tsutsumi, M | 1 |
Andriaov, AY | 1 |
Brewer, KL | 1 |
Hardin, JS | 1 |
Sánchez-Fidalgo, S | 1 |
Villegas, I | 1 |
Martín, A | 1 |
Sánchez-Hidalgo, M | 1 |
Alarcón de la Lastra, C | 1 |
Li, M | 1 |
Srinivas, S | 1 |
Brzozowski, T | 1 |
Konturek, PC | 1 |
Chlopicki, S | 1 |
Sliwowski, Z | 1 |
Pawlik, M | 1 |
Ptak-Belowska, A | 1 |
Kwiecien, S | 1 |
Drozdowicz, D | 1 |
Pajdo, R | 1 |
Slonimska, E | 1 |
Konturek, SJ | 1 |
Pawlik, WW | 1 |
Yamori, M | 1 |
Oishi, R | 1 |
Gomita, Y | 1 |
Saeki, K | 1 |
Kunin, CM | 1 |
Hua, TH | 1 |
Krishnan, C | 1 |
Van Arsdale White, L | 1 |
Hacker, J | 1 |
Cossarizza, A | 1 |
Mussini, C | 1 |
Mongiardo, N | 1 |
Borghi, V | 1 |
Sabbatini, A | 1 |
De Rienzo, B | 1 |
Franceschi, C | 1 |
Kobayashi, Y | 1 |
Goto, Y | 1 |
Daikoku, S | 1 |
Itoh, A | 1 |
Miyazaki, S | 1 |
Ohshima, S | 1 |
Nonogi, H | 1 |
Haze, K | 1 |
Noguchi, K | 1 |
Matsuzaki, T | 1 |
Ojiri, Y | 1 |
Koyama, T | 1 |
Nakasone, J | 1 |
Sakanashi, M | 1 |
Shinohara, H | 1 |
Nishikado, A | 1 |
Wakatsuki, T | 1 |
Sakabe, K | 1 |
Ito, S | 1 |
Johnson, JR | 1 |
Delavari, P | 1 |
O'Bryan, TT | 1 |
Gratz, S | 1 |
Rennen, HJ | 1 |
Boerman, OC | 1 |
Oyen, WJ | 1 |
Corstens, FH | 1 |
Marak, GE | 1 |
Sery, TW | 1 |
Gregerson, D | 1 |
Donoso, LA | 1 |
Rao, NA | 1 |
Shevata, VN | 1 |
Geviak, OM | 1 |
Ovchinnikova, NI | 1 |
Smythies, JR | 1 |
Tabaqchali, S | 1 |
Pallis, C | 1 |
Seĭfullin, FKh | 1 |
Trux, F | 1 |
Grossmann, K | 1 |
Giegler, I | 1 |
7 trials available for niacinamide and Acute Disease
Article | Year |
---|---|
[Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy].
Topics: Acute Disease; Adult; Brain Diseases, Metabolic; Drug Combinations; Female; Flavin Mononucleotide; H | 2013 |
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Area Under Curve; Benzenesulfonates; | 2010 |
[Correction of nonspecific damages in acute poisoning of substance from the group of opiate drug in patients in critical condition].
Topics: Acute Disease; Adult; Analgesics, Opioid; Critical Illness; Female; Humans; Inosine Diphosphate; Len | 2011 |
[Pharmacologic correction of hypoxia in patients with acute cerebral failure due to acute poisoning with carbon monoxide and combustion products].
Topics: Acute Disease; Adult; Blood Gas Analysis; Carbon Monoxide Poisoning; Combined Modality Therapy; Crit | 2012 |
Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction.
Topics: Acute Disease; Anti-Arrhythmia Agents; Humans; Injections, Intravenous; Myocardial Infarction; Myoca | 1998 |
[Rheopyrine and nicotinamide in the ambulatory treatment of acute thrombophlebitis].
Topics: Acute Disease; Ambulatory Care; Aminopyrine; Clinical Trials as Topic; Drug Combinations; Drug Thera | 1989 |
Nicotinic acid in the treatment of schizophrenia.
Topics: Acute Disease; Blood Glucose; Chronic Disease; Clinical Trials as Topic; Humans; Hyperbilirubinemia; | 1973 |
40 other studies available for niacinamide and Acute Disease
Article | Year |
---|---|
A Noninvasive Urine Metabolome Panel as Potential Biomarkers for Diagnosis of T Cell-Mediated Renal Transplant Rejection.
Topics: Acute Disease; Adenosine Diphosphate; Adult; Biomarkers; Cholesterol Esters; Cross-Sectional Studies | 2020 |
The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients.
Topics: Acute Disease; Adult; Asian People; China; Drug Therapy; Female; fms-Like Tyrosine Kinase 3; Hematop | 2018 |
[Protective effect of cytoflavin and its components in mice with acute alloxan intoxication].
Topics: Acute Disease; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Drug Combinations; Female | 2013 |
[Experimental evaluation of reamberin and cytoflavin effects on the course and outcome of acute burn injury].
Topics: Acute Disease; Animals; Burns; Drug Combinations; Drug Evaluation, Preclinical; Female; Flavin Monon | 2013 |
[Pharmacological treatment of hemorheological disorders in children with acute respiratory viral infection].
Topics: Acute Disease; Blood Viscosity; Child; Child, Preschool; Drug Combinations; Erythrocyte Aggregation; | 2013 |
[PREVENTION AND CORRECTION OF PULMONARY COMPLICATIONS FOR SEVERE ACUTE PANCREATITIS].
Topics: Acute Disease; Acute Lung Injury; Adult; Aged; Antioxidants; Capillary Permeability; Diaphragm; Drug | 2015 |
Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells.
Topics: Acute Disease; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Combined Chemothera | 2016 |
[Correction of a reperfusion dysfunction in acute intestinal obstruction].
Topics: Acute Disease; Animals; Digestive System Surgical Procedures; Disease Models, Animal; Dogs; Drug Com | 2008 |
Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib.
Topics: Acute Disease; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chemical a | 2009 |
Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation.
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzene | 2009 |
Sorafenib - a small molecule with big promise?
Topics: Abdominal Pain; Acute Disease; Area Under Curve; Benzenesulfonates; Diarrhea; Dose-Response Relation | 2010 |
Sorafenib-induced acute pancreatitis.
Topics: Acute Disease; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Humans; Liver Ne | 2010 |
[Pharmacological correction of hypoxic and free-radical disorders in patients with acute myocardial infarction complicated by acute heart failure].
Topics: Acute Disease; Critical Care; Drug Combinations; Flavin Mononucleotide; Fluorocarbons; Free Radicals | 2010 |
Sorafenib-induced severe acute hepatitis in a stable liver transplant recipient.
Topics: Acute Disease; Antineoplastic Agents; Benzenesulfonates; Bilirubin; Carcinoma, Hepatocellular; Chemi | 2010 |
Metabolomic study on vitamins B₁, B₂, and PP supplementation to improve serum metabolic profiles in mice under acute hypoxia based on ¹H NMR analysis.
Topics: Acute Disease; Animals; Dose-Response Relationship, Drug; Hypoxia; Lipid Metabolism; Magnetic Resona | 2010 |
[The use of cytoflavin in combined neurometabolic therapy of acute cerebral insufficiency associated with acute poisoning with neurotropic poisons].
Topics: Acute Disease; CD3 Complex; CD4 Antigens; CD8 Antigens; Coma; Critical Illness; Drug Combinations; F | 2010 |
Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner.
Topics: Acute Disease; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Blotting, | 2011 |
[Clinical efficacy of cytoflavin in the combined treatment of patients during acute phase of ischemic stroke].
Topics: Acute Disease; Adult; Aged; Brain Ischemia; Drug Combinations; Electroencephalography; Flavin Mononu | 2011 |
[Comparative experimental study of antioxidant efficiency in treatment of acute pancreatitis].
Topics: Acute Disease; Animals; Antioxidants; Disease Models, Animal; Drug Combinations; Flavin Mononucleoti | 2011 |
[Methods for the prevention and treatment of toxico-hypoxic encephalopathy in patients with acute severe poisoning].
Topics: Acute Disease; Adult; Antidotes; Drug Combinations; Electroencephalography; Flavin Mononucleotide; H | 2011 |
[A case of fatal clinical course with reversible acute cardiac failure and glucose intolerance during sorafenib therapy for metastatic renal cell carcinoma].
Topics: Acute Disease; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Glucose Intole | 2012 |
[Approaches to the improvement of treatment efficacy in patients with acute severe asaleptin intoxication complicated by acute respiratory insufficiency of mixed genesis].
Topics: Acute Disease; Adult; Antipsychotic Agents; Clozapine; Drug Combinations; Female; Flavin Mononucleot | 2012 |
Niacinamide. Monograph.
Topics: Acute Disease; Animals; Anticonvulsants; Diabetes Mellitus, Type 1; Drug Interactions; Humans; Niaci | 2002 |
Neuroprotective effects of nicotinamide after experimental spinal cord injury.
Topics: Acute Disease; Animals; Disease Models, Animal; Excitatory Amino Acid Agonists; Inflammation; Inject | 2004 |
PARP inhibition reduces acute colonic inflammation in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Colitis; Colon; Cyclooxygenase 1; Cyclooxygenase 2 | 2007 |
Acute pancreatitis associated with sorafenib.
Topics: Acute Disease; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; E | 2007 |
Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves.
Topics: Acute Disease; Animals; Epoprostenol; Gastric Acid; Gastric Mucosa; Male; Neurons, Afferent; Niacina | 2008 |
Effect of acute and chronic immobilization stress on plasma levels of nicorandil administered orally to rats.
Topics: Acute Disease; Administration, Oral; Animals; Chronic Disease; Intestinal Absorption; Male; Niacinam | 1994 |
Isolation of a nicotinamide-requiring clone of Escherichia coli O18:K1:H7 from women with acute cystitis: resemblance to strains found in neonatal meningitis.
Topics: Acute Disease; Bacteriuria; Culture Media; Cystitis; Escherichia coli; Escherichia coli Infections; | 1993 |
Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome.
Topics: Acetylcarnitine; Acetylcysteine; Acute Disease; Adult; Antioxidants; Apoptosis; CD4 Lymphocyte Count | 1997 |
Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Circulation; Cromakalim; Disease Models, Animal; Do | 1998 |
The effects of nicorandil on electrophysiological changes in acute myocardial ischemia and reperfusion.
Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Drug Evaluation, Precl | 1998 |
Escherichia coli O18:K1:H7 isolates from patients with acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles.
Topics: Acute Disease; Bacterial Outer Membrane Proteins; Cystitis; Escherichia coli; Escherichia coli Infec | 2001 |
Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits.
Topics: Acute Disease; Animals; Colitis; Colon; Female; Gamma Cameras; Granulocytes; Hydrazines; Interleukin | 2001 |
Pharmacologic modulation of acute uveitis with aminonicotinamide.
Topics: 6-Aminonicotinamide; Acute Disease; Animals; Antigens; Arrestin; Ciliary Body; Eye Proteins; Immuniz | 1990 |
[The vitamin B6, PP and C allowances of patients in the acute period of ischemic stroke].
Topics: Acute Disease; Adult; Aged; Ascorbic Acid; Brain Ischemia; Female; Humans; Male; Middle Aged; Niacin | 1989 |
Letter: Nicotinamide treatment of schizophrenia.
Topics: Acute Disease; Adult; Bipolar Disorder; Chronic Disease; Drug Evaluation; Female; Humans; Male; Niac | 1973 |
Reversible nicotinamide-deficiency encephalopathy in a patient with jejunal diverticulosis.
Topics: Acute Disease; Aged; Brain Diseases; Diverticulum; Female; Humans; Injections, Intravenous; Jejunum; | 1970 |
[The effect of coamide on the structure of the nerve elements in the skin and muscles of irradiated animals].
Topics: Acute Disease; Animals; Cobalt; Male; Muscles; Nerve Regeneration; Niacinamide; Peripheral Nerves; P | 1969 |
[Acute intermittent porphyria (our personal observations in a family)].
Topics: Acute Disease; Adrenocorticotropic Hormone; Adult; Biopsy; Chlorpromazine; Cytochromes; Dimercaprol; | 1971 |